(E)-N-(2-aminophenyl)-3-[2-(4-methoxyphenyl)-1,3-thiazol-5-yl]prop-2-enamide
C19H17N3O2S — CID 166627826
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-N-(2-aminophenyl)-3-[2-(4-methoxyphenyl)-1,3-thiazol-5-yl]prop-2-enamide
(E)-N-(2-aminophenyl)-3-[2-(4-methoxyphenyl)-1,3-thiazol-5-yl]prop-2-enamide (PubChem CID 166627826) has the molecular formula C19H17N3O2S and a molecular weight of 351.43 g/mol. Its IUPAC name is (E)-N-(2-aminophenyl)-3-[2-(4-methoxyphenyl)-1,3-thiazol-5-yl]prop-2-enamide.
Molecular Properties
| Compound Name | (E)-N-(2-aminophenyl)-3-[2-(4-methoxyphenyl)-1,3-thiazol-5-yl]prop-2-enamide |
|---|---|
| PubChem CID | 166627826 |
| Molecular Formula | C19H17N3O2S |
| Molecular Weight | 351.43 g/mol |
| Exact Mass | 351.10 |
| IUPAC Name | (E)-N-(2-aminophenyl)-3-[2-(4-methoxyphenyl)-1,3-thiazol-5-yl]prop-2-enamide |
| SMILES | COc1ccc(-c2ncc(/C=C/C(=O)Nc3ccccc3N)s2)cc1 |
| InChI | InChI=1S/C19H17N3O2S/c1-24-14-8-6-13(7-9-14)19-21-12-15(25-19)10-11-18(23)22-17-5-3-2-4-16(17)20/h2-12H,20H2,1H3,(H,22,23)/b11-10+ |
| InChIKey | HYVOBVJIELUKNJ-ZHACJKMWSA-N |
| XLogP | 4.05 |
| TPSA | 77.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 351.43 |
| LogP ≤ 5 | 4.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166627826 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.